Document Type

Patent

Publication Date

September 2014

Patent Number

8822524

CPC

A61K 31/404(20130101), A61K 31/132(20130101), C07D 209/04(20130101), C07C 255/50(20130101), C07C 255/51(20130101)

Abstract

Disclosed herein is a species of peptide and non-peptide inhibitors of Akt, an oncogenic protein. Beginning with a residue of Akt target substrate GSK-3, the functional domains of the GSK-3 residue were characterized. Functionally homologous non-peptide groups were substituted for the amino acids of the GSK-3 creating a hybrid peptide-non-peptide and non-peptide compounds capable of binding to Akt. The non-peptide compounds show increased stability and rigidity compared to peptide counterparts and are less susceptible to degradation. The bound non-peptide compounds exhibit an inhibitory effect on Akt, similar to peptide-based Akt inhibitors.

Application Number

12/480,329

Assignees

University of South Florida Yale University

Filing Date

06/08/2009

Primary/U.S. Class

514/415

Share

COinS